SCHEMBL20535103

SCHEMBL20535103

COC(=O)C(C)(C)S(=O)(=O)c1cccc(Br)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
ATM Q13315 1/20 0.43
BRD4 O60885 1/20 0.41
HSD17B2 P37059 1/20 0.41
KAT6A Q92794 2/20 0.39
FLT1 P17948 1/20 0.39
FLT4 P35916 1/20 0.39
KDR P35968 1/20 0.39
PGR P06401 1/20 0.39
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
WDR5 P61964 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22615746 0.82 NR1H2 (0.47) NR1H2NR1H3FLT1FLT4KDR
SCHEMBL1498483 0.79 CA1 (0.54) HSD17B2KAT6APGRMEN1KMT2A
SCHEMBL12325608 0.77 ALDH1A1 (0.44) ATMBRD4HSD17B2PGRMEN1
SCHEMBL21760585 0.75 SMN1; SMN2 (0.54) KMT2ASMN1; SMN2TSHRWDR5GAA
SCHEMBL2071185 0.74 NR1H2 (0.52) NR1H2NR1H3ATM
SCHEMBL3566598 0.72 PGR (0.50) ATMBRD4HSD17B2KAT6AFLT1
SCHEMBL26966928 0.72 ELANE (0.50) KMT2ASMN1; SMN2GAAPHGDH
SCHEMBL3650194 0.71 KCNN4 (0.46) MEN1KMT2ASMN1; SMN2TSHRNPSR1
SCHEMBL31121937 0.71 CNR1 (0.47) MEN1KMT2ASMN1; SMN2TSHRNPSR1
SCHEMBL349736 0.71 CNR2 (0.52) PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2020-04-16 US disclosed
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2020-04-16 US disclosed
EP-3609880-A1 LIVER X RECEPTORS (LXR) MODULATORS Phenex-FXR GmbH (DE) 2020-02-19 EP disclosed
CN-110546144-A Liver X Receptor (LXR) modulators PHENEX FXR GMBH 2019-12-06 CN disclosed
WO-2018188795-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2018-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS NR1H2, NR1H3, NR1H4 NR1H2 1/4885NR1H3 2/4885ATM 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.